Skin Care Drug Co. Timber Gets OK For Ch. 11 Sale To Lender
By Vince Sullivan · January 22, 2024, 6:22 PM EST
A Delaware bankruptcy judge on Monday approved dermatology drug developer Timber Pharmaceuticals' plan for a Chapter 11 sale of its assets, with the debtor telling the court it intended to close...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login